Digital biomarkers are a new category of biomarkers that use digital technologies to measure and track physiological and behavioral indicators of disease or health. Unlike traditional biomarkers, which are typically assessed through a blood sample or imaging test, digital biomarkers can be collected remotely and in real-time using wearable sensors, 智能手机, or other digital devices. Examples of digital biomarkers include heart rate variability, sleep patterns, activity levels, and even vocal patterns. By analyzing these data points through machine learning and artificial intelligence algorithms, healthcare professionals can gain insights into an individual’s health status and track changes over time. The global digital biomarkers market size is projected to grow by USD 23.2 十亿来自 2023 到 2029, 复合年增长率为 44.55 百分, 根据最新市场数据.

该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global digital biomarkers market. 它提供了对市场的定量分析，使利益相关者能够利用当前的市场机会. 该报告还根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场.

该行业报告提供了全球市场的市场估计和预测, 其次是类型的详细分析, system components, 应用, 最终用户, 和地区. The global market for digital biomarkers can be segmented by type: 临床试验, clinical settings. 在这些当中, the clinical settings segment was accounted for the highest revenue generator in 2022. Digital biomarkers market is further segmented by system components: wearables, mobile apps, implantables, data integration software. The wearables segment is estimated to account for the largest share of the global digital biomarkers market. 根据应用, the digital biomarkers market is segmented into: gastrointestinal diseases, sleep and movement disorders, 心血管, psychiatric disorders (mood and behavior), chronic pain, neurodegenerative diseases, diabetes, respiratory diseases, 其他的. The cardiovascular segment held the largest share of the global digital biomarkers market in 2022 预计在预测期内将持有其份额. 基于最终用户, the digital biomarkers market also can be divided into: 生物制药公司, 付款人, providers. 在 2022, the biopharmaceutical companies segment made up the largest share of revenue generated by the digital biomarkers market. Digital biomarkers market by region is categorized into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美.

市场细分
按类型: 临床试验, clinical settings
By system components: wearables, mobile apps, implantables, data integration software
按申请: gastrointestinal diseases, sleep and movement disorders, 心血管, psychiatric disorders (mood and behavior), chronic pain, neurodegenerative diseases, diabetes, respiratory diseases, 其他的
按最终用户: 生物制药公司, 付款人, providers
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美

The report has also analysed the competitive landscape of the global digital biomarkers market with some of the key players being Alphabet Inc., AliveCor Inc., Akili Interactive Labs, 公司, Dassault Systèmes SE, IXICO plc, 皇家飞利浦公司, Quanterix Corp., 除其他外. 在这份报告中, 全面分析关键参与者及其策略，以了解市场的竞争前景.
*索取免费样品以获得完整的公司列表

报告范围
• To analyze and forecast the market size of the global digital biomarkers market.
• To classify and forecast the global digital biomarkers market based on type, system components, 应用, 最终用户, 地区.
• To identify drivers and challenges for the global digital biomarkers market.
• 检查竞争性发展，例如合并 & 收购, 协议, 合作与伙伴关系, ETC。, in the global digital biomarkers market.
• To identify and analyze the profile of leading players operating in the global digital biomarkers market.

为什么选择这份报告
• Gain a reliable outlook of the global digital biomarkers market forecasts from 2023 到 2029 跨场景.
• 确定投资的增长领域.
• 通过公司简介和市场数据保持领先于竞争对手.
• 以 Excel 格式进行跨场景分析的市场预估.
• 三个月的战略咨询和研究支持.
• 为单用户许可证提供打印验证.